Connect Biopharma Holdings Limited
CNTB
$2.55
$0.010.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.95M | 233.00K | 64.00K | 762.00K | 1.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.95M | 233.00K | 64.00K | 762.00K | 1.97M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 2.95M | 233.00K | 64.00K | 762.00K | 1.97M |
| SG&A Expenses | 19.67M | 20.27M | 20.34M | 20.18M | 18.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 73.37M | 66.47M | 58.14M | 52.93M | 48.50M |
| Operating Income | -70.41M | -66.23M | -58.07M | -52.17M | -46.54M |
| Income Before Tax | -68.80M | -64.42M | -55.28M | -49.00M | -44.68M |
| Income Tax Expenses | 196.00K | 191.00K | 197.00K | 276.00K | 272.00K |
| Earnings from Continuing Operations | -68.99 | -64.61 | -55.48 | -49.28 | -44.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -68.99M | -64.61M | -55.48M | -49.28M | -44.95M |
| EBIT | -70.41M | -66.23M | -58.07M | -52.17M | -46.54M |
| EBITDA | -69.73M | -65.54M | -57.37M | -51.49M | -45.86M |
| EPS Basic | -1.20 | -1.15 | -1.00 | -0.89 | -0.81 |
| Normalized Basic EPS | -0.75 | -0.72 | -0.62 | -0.55 | -0.48 |
| EPS Diluted | -1.20 | -1.15 | -1.00 | -0.89 | -0.81 |
| Normalized Diluted EPS | -0.75 | -0.72 | -0.62 | -0.55 | -0.48 |
| Average Basic Shares Outstanding | 231.21M | 223.83M | 222.63M | 221.88M | 221.41M |
| Average Diluted Shares Outstanding | 231.21M | 223.83M | 222.63M | 221.88M | 221.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |